Physician profile
Robert A Salk
NPI 1548280555
$4,186.33
in general payments reported to CMS, 2019-2025
32 companies · $31.45 in 2025
The $31.45 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,508 · 2020: $578 · 2021: $819 · 2022: $371 · 2023: $637 · 2024: $243 · 2025: $31.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $705.31 | 2019 | |
| Abbvie INC. | $504.68 | 2019-2025 | |
| Myovant Sciences INC. | $398.19 | 2021-2022 | |
| Exeltis, USA INC. | $293.50 | 2020-2024 | Slynd, Tyblume |
| Sumitomo Pharma America, INC. | $272.45 | 2023-2024 | Myfembree, Gemtesa |
| Pfizer INC. | $260.27 | 2019-2023 | |
| Therapeuticsmd, INC. | $254.01 | 2020-2022 | |
| Astellas Pharma US INC | $253.42 | 2019-2024 | Veozah |
| Amgen INC. | $158.62 | 2019-2021 | |
| Allergan, INC. | $125.75 | 2019 | |
| Hologic Sales and Service, LLC | $106.06 | 2021-2024 | Myosure Tissue Removal Device |
| Mylan Pharmaceuticals INC. | $74.60 | 2021 | |
| Daiichi Sankyo INC. | $69.37 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $65.70 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.95 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $62.18 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $59.56 | 2020 | |
| Evofem Biosciences, INC. | $52.48 | 2021 | |
| Ethicon US, LLC | $51.93 | 2019-2021 | |
| Coopersurgical, INC. | $51.35 | 2019-2024 | Summit Doppler |
| Agile Therapeutics, INC. | $35.96 | 2021-2022 | |
| Smith+Nephew, INC. | $33.67 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $29.20 | 2021 | |
| Covidien Lp | $27.96 | 2019 | |
| Avion Pharmaceuticals | $24.59 | 2019 | |
| Roche Diagnostics Corporation | $24.58 | 2020 | |
| Eisai INC. | $24.26 | 2019 | |
| Mayne Pharma Commercial LLC | $23.98 | 2021 | |
| Medicem INC. | $23.08 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.87 | 2020 | |
| Novo Nordisk INC | $16.05 | 2019 | |
| Medtronic, INC. | $15.75 | 2025 | V-Loc 180 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Salk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.